- Home
- IMNN vs OXBR Comparison
IMNN vs OXBR Comparison
Compare IMNN & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- OXBR
- Stock Information
- Founded
- IMNN 1982
- OXBR 2013
- Country
- IMNN United States
- OXBR Cayman Islands
- Employees
- IMNN N/A
- OXBR N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- OXBR Property-Casualty Insurers
- Sector
- IMNN Health Care
- OXBR Finance
- Exchange
- IMNN Nasdaq
- OXBR Nasdaq
- Market Cap
- IMNN 12.1M
- OXBR 12.7M
- IPO Year
- IMNN 1985
- OXBR 2014
- Fundamental
- Price
- IMNN $0.77
- OXBR $1.75
- Analyst Decision
- IMNN Buy
- OXBR Strong Buy
- Analyst Count
- IMNN 2
- OXBR 1
- Target Price
- IMNN $14.00
- OXBR $5.00
- AVG Volume (30 Days)
- IMNN 5.4M
- OXBR 96.7K
- Earning Date
- IMNN 08-13-2025
- OXBR 08-07-2025
- Dividend Yield
- IMNN N/A
- OXBR N/A
- EPS Growth
- IMNN N/A
- OXBR N/A
- EPS
- IMNN N/A
- OXBR N/A
- Revenue
- IMNN N/A
- OXBR $1,363,000.00
- Revenue This Year
- IMNN N/A
- OXBR $497.99
- Revenue Next Year
- IMNN N/A
- OXBR $42.14
- P/E Ratio
- IMNN N/A
- OXBR N/A
- Revenue Growth
- IMNN N/A
- OXBR N/A
- 52 Week Low
- IMNN $0.37
- OXBR $1.27
- 52 Week High
- IMNN $3.65
- OXBR $5.81
- Technical
- Relative Strength Index (RSI)
- IMNN 40.14
- OXBR 57.92
- Support Level
- IMNN $0.93
- OXBR $1.65
- Resistance Level
- IMNN $1.03
- OXBR $1.94
- Average True Range (ATR)
- IMNN 0.18
- OXBR 0.18
- MACD
- IMNN -0.10
- OXBR 0.03
- Stochastic Oscillator
- IMNN 1.39
- OXBR 90.40
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.